论文部分内容阅读
目的:分析主要临床病理因素和治疗因素对乳腺癌术后胸壁复发的影响,降低复发率。方法:回顾性分析39例患者的临床资料。结果:T1和T2的平均无瘤间期显著长于T3(P<0.05),腋淋巴结阳性数0～3个组的平均无瘤间期显著长于3个以上组(P<0.05),完成综合治疗组的平均无瘤间期显著长于未完成组(P<0.05)。未完成综合治疗的主要原因是对综合治疗不重视。结论:原发肿瘤的大小,腋淋巴结转移数和综合治疗的实施对乳腺癌术后胸壁复发有显著影响,在乳腺癌治疗过程中应做到早期发现,早期治疗,重视综合治疗。
Objective: To analyze the effects of major clinicopathologic factors and therapeutic factors on the recurrence of chest wall after breast cancer surgery and reduce the recurrence rate. Methods: The clinical data of 39 patients were retrospectively analyzed. Results: The average tumor-free interval between T1 and T2 was significantly longer than T3 (P<0.05). The average tumor-free interval between 0 to 3 axillary lymph node positive groups was significantly longer than 3 or more groups (P<0.05). The average tumor-free interval was significantly longer in the group than in the uncompleted group (P < 0.05). The main reason for not completing comprehensive treatment is not paying attention to comprehensive treatment. Conclusion: The size of the primary tumor, the number of axillary lymph node metastases and the implementation of comprehensive therapy have a significant effect on breast wall recurrence after breast cancer surgery. Early detection, early treatment, and comprehensive treatment should be done during breast cancer treatment.